Total Funding
50
Total FundingGrant raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
48747
EIP Pharma is a clinical stage therapeutics company developing drugs to treat neurodegenerative diseases.
- Sylvie Grégoire: Co-Founder
Kelly Blackburn: Vice President Clinical DevelopmentPast Role: aTyr Pharma, Vice President, Clinical Affairs
About the Company
EIP Pharma is a clinical stage therapeutics company that focuses on the development and commercialization of drug treatments for neurodegenerative diseases, with a particular emphasis on the early stages of the neurodegenerative process. The company's drug promotes function recovery in patients suffering from acute neurologic injury.
Women Founded
